20-hydroxy-5,8,11,14-eicosatetraenoic acid has been researched along with zm 241385 in 1 studies
| Studies (20-hydroxy-5,8,11,14-eicosatetraenoic acid) | Trials (20-hydroxy-5,8,11,14-eicosatetraenoic acid) | Recent Studies (post-2010) (20-hydroxy-5,8,11,14-eicosatetraenoic acid) | Studies (zm 241385) | Trials (zm 241385) | Recent Studies (post-2010) (zm 241385) |
|---|---|---|---|---|---|
| 640 | 13 | 233 | 401 | 3 | 124 |
| Protein | Taxonomy | 20-hydroxy-5,8,11,14-eicosatetraenoic acid (IC50) | zm 241385 (IC50) |
|---|---|---|---|
| Adenosine receptor A3 | Rattus norvegicus (Norway rat) | 0.0949 | |
| Adenosine receptor A2a | Homo sapiens (human) | 0.0216 | |
| Adenosine receptor A2b | Homo sapiens (human) | 0.0646 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Carroll, MA; Doumad, AB; Falck, JR; Li, J; Liclican, EL; Stier, CT; Wang, J | 1 |
1 other study(ies) available for 20-hydroxy-5,8,11,14-eicosatetraenoic acid and zm 241385
| Article | Year |
|---|---|
Inhibition of the adenosine2A receptor-epoxyeicosatrienoic acid pathway renders Dahl salt-resistant rats hypertensive.
Topics: Adrenergic alpha-2 Receptor Antagonists; Amides; Animals; Blood Pressure; Drinking; Eicosanoids; Hydroxyeicosatetraenoic Acids; Hypertension, Renal; Male; Natriuresis; Oxidoreductases; Rats; Rats, Inbred Dahl; Receptors, Adrenergic, alpha-2; Sodium Chloride, Dietary; Triazines; Triazoles | 2009 |